Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 27 min ago
PreprintCC BYbioRxiv

CAR T cell targeting of inflammatory myeloid progenitors in the bone marrow remodels border-associated macrophages and reverses cognitive aging

3 more authors
  1. 1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA

Abstract

Aging is associated with progressive neuroinflammation and cognitive decline, yet the cellular sources that sustain this process and whether they can be targeted peripherally remain unclear. Here, we identify inflammatory border-associated macrophages (BAMs) as key drivers of neuroinflammation in aging and show that their therapeutic and prophylactic elimination through intrathecal CAR T cell therapy restores cognitive performance in mouse models of aging and Alzheimer's disease. Furthermore, targeting of aged inflammatory bone marrow myeloid progenitors through either intravenous CAR T cells, which do not infiltrate the brain, or through transplantation of CAR T-treated progenitors is sufficient to reduce neuroinflammation and cognitive impairment. These findings reveal that bone marrow myeloid progenitors harbor a heritable inflammatory transcriptional state that is transmitted to their BAM progeny, driving neuroinflammation and cognitive deterioration, and conserved in human aging. Critically, this proinflammatory state is marked by the upregulation of surface proteins, enabling precise peripheral CAR T cell targeting of these progenitors for long-lasting therapeutic effects in cognitive aging.

Related

  1. Low-molecular-weight Ulva lacinulata extract exhibiting anti-inflammatory and pro-autophagic activities in RAW 264.7 macrophages: a promising candidate for the development of active ingredients targeting low-grade inflammation
    Julien Cherfan, Dhanish Heerah, Pierre-Edouard Bodet +15
    HALPreprintLicence not statedFull textEcologyHAL
  2. Tumor immune cell targeting chimeras reprogram tumor-associated macrophages
    Mariko Morimoto, David S. Roberts, Ru M. Wen +6
    Nature Chemical BiologyPeer-reviewedLicence not statedFull text7 citedImmunologyOpenAlex
  3. Precision targeting of tumor-associated macrophages via a 6-substituted pyrrolo[2,3-d]pyrimidine chimeric molecule for enhanced cancer immunotherapy
    Yining Zhang, Binghao Guo, Lixiao Guo +16
    Communications ChemistryPeer-reviewedCC BY-NC-ND 4.0Full textImmunologyCrossref
  4. Targeting O-GlcNAcylation in tumor-associated macrophages: from metabolic reprogramming to osteolytic niche formation in bone-invasive solid tumors
    Shengqian Li, Yuan Zhi, Shaoming Li +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  5. 981 Tumor-mediated innate training of neutrophil progenitors involves FOXO1 activation and promotes immunotherapy-associated colitis
    Michael Plebanek, Balamayooran Theivanthiran, Y-Van Nguyen +2
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
BibTeX
@misc{harris2026cell,
  title = {{CAR T cell targeting of inflammatory myeloid progenitors in the bone marrow remodels border-associated macrophages and reverses cognitive aging}},
  author = {A. S. Harris and J. A. Rouse and G. Guo and I. Fernandez-Maestre and S. Pal and B. Oh and S. Li and W. Y. See and A. Anderson and J. Gewolb and M. Soethout and J. Habel and R. Utama and C. R. Vakoc and C. Amor},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.27.754777},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.27.754777v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - CAR T cell targeting of inflammatory myeloid progenitors in the bone marrow remodels border-associated macrophages and reverses cognitive aging
AU  - A. S. Harris
AU  - J. A. Rouse
AU  - G. Guo
AU  - I. Fernandez-Maestre
AU  - S. Pal
AU  - B. Oh
AU  - S. Li
AU  - W. Y. See
AU  - A. Anderson
AU  - J. Gewolb
AU  - M. Soethout
AU  - J. Habel
AU  - R. Utama
AU  - C. R. Vakoc
AU  - C. Amor
PY  - 2026
DA  - 2026/09/27
PB  - bioRxiv
DO  - 10.64898/2026.09.27.754777
UR  - https://www.biorxiv.org/content/10.64898/2026.09.27.754777v1
AB  - Aging is associated with progressive neuroinflammation and cognitive decline, yet the cellular sources that sustain this process and whether they can be targeted peripherally remain unclear. Here, we identify inflammatory border-associated macrophages (BAMs) as key drivers of neuroinflammation in aging and show that their therapeutic and prophylactic elimination through intrathecal CAR T cell therapy restores cognitive performance in mouse models of aging and Alzheimer's disease. Furthermore, targeting of aged inflammatory bone marrow myeloid progenitors through either intravenous CAR T cells, which do not infiltrate the brain, or through transplantation of CAR T-treated progenitors is sufficient to reduce neuroinflammation and cognitive impairment. These findings reveal that bone marrow myeloid progenitors harbor a heritable inflammatory transcriptional state that is transmitted to their BAM progeny, driving neuroinflammation and cognitive deterioration, and conserved in human aging. Critically, this proinflammatory state is marked by the upregulation of surface proteins, enabling precise peripheral CAR T cell targeting of these progenitors for long-lasting therapeutic effects in cognitive aging.
ER  -